Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin

Vaccine

Volumn 16, Issue 7, 1998, Pages 741-745

  Higaki, Megumu ^a   Takase, Tsugiko ^a   Igarashi, Rie ^a   Suzuki, Yujiro ^b   Aizawa, Chikara ^b   Mizushima, Yutaka ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO INSTITUTE   (Japan)

Author keywords

Influenza HA vaccine; Intranasal immunization; Sodium polystyrene sulfonate

Indexed keywords

COLESTYRAMINE; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; POLYSTYRENE DERIVATIVE; POLYSTYRENESULFONATE CALCIUM; POLYSTYRENESULFONATE SODIUM; POLYSTYRENESULFONIC ACID; RESIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNOGLOBULIN A; INFLUENZA VACCINES; ION EXCHANGE RESINS; MICE; NASAL CAVITY; PARTICLE SIZE; POLYSTYRENES;

EID: 0032053613     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00248-X     Document Type: Article

References (18)

1. 1 Kimura, M., Sakai, H., Takesue, R., Ozaki, K., Minamitani, M. and Nakayama, M. et al. Intranasal administration of influenza inactivated HA vaccine. Clin. Virol. 1987, 15, 407
2. 2 Tamura, S., Samegai, Y., Kurata, H., Nagamine, T., Aizawa, C. and Kurata, T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 1988, 6, 409
3. 3 Walker, R.I. New strategies for using mucosal vaccine to achieve more effective immunization. Vaccine 1994, 12, 387
4. 4 Altman, A. and Dixon, F.J. Immunomodifiers in vaccines. Adv. Vet. Sci. Comp. Med. 1989, 33, 301
5. 5 Oka, T., Honda, T., Ohkuma, K., Sakoh, M. and Nonaka, S. Influenza vaccine: enhancement of immune response by application of carboxy-vinylpolymer. Vaccine 1990, 8, 573
6. 6 Alpar, H.O., Bowen, J.C. and Brown, M.R.W. Effectiveness of liposomes as adjuvants of orally and nasally administered tetanus toxoid. Int. J. Pharm. 1992, 88, 335
7. 7 Almeida, A.J. and Alpar, H.O. Nasal delivery of vaccines. J. Drug Targeting 1996, 3, 455
8. 8 Guink, N.E., Kris, R.M., Goodman-Snitkoff, G., Small, P.A. and Mannino, R.J. Intranasal immunization with proteoliposomes protects against influenza. Vaccine 1989, 7, 147
9. 9 Davenport, F.M., Hennesy, A.V., Brandon, F.M., Webster, R.G., Barrett, C.D. Jr. and Lease. G.O. Comparison of serologic and febrile responses in humans to vaccination with influenza A viruses or their haemagglutinins. J. Lab. Clin. Med. 1964, 63, 5
10. 10 Elson, C.O. and Ealding, W. Lefkowitz, J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J. Immunol. Methods 1984, 67, 101
11. 11 Kuper, C.F., Koornstra, P.J. and Hameleers, D.M.H. et al. The role of nasopharyngeal lymphoid tissue. Immunol Today 1992, 13, 219
12. 12 Duchen, D. and Ponchel, G. Nasal administration: a tool for tomorrow's systemic administration of drugs. Drug Develop. Industr. Pharm. 1993, 19, 101
13. 13 O'Hagan, D.T. Novel nonreplicating antigen delivery systems. Curt. Opin. Infect. Dis. 1990, 3, 393
14. 14 Bjork, E., Isaksson, U., Edman, P. and Artursson, P. Starch microspheres induce pulsative delivery of drugs and peptides across the epithelial barrier by reversible separation of the tight junctions. J. Drug Targeting 1995, 2, 501
15. 15 Burton, S., Washington, N., Steele, R.J.C., Musson, R. and Feely, L. Intragastric distribution of ion-exchange resins: a drug delivery system for the topical treatment of the gastric mucosa. J. Pharm. Pharmacol. 1995, 47, 901
16. 16 Jani, P.U., Florence, A.T. and McCarthy, D.E. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int. J. Pharmaceut. 1992, 84, 245
17. 17 Kreuter, J., Berg, U., Liehl, E., Soliva, M. and Speiser, P.P. Influence of the particle size on the adjuvant effect of particulate polymeric adjuvants. Vaccine 1986, 4, 125
18. 18 Marianaro, M., Boyaka, P.N. and Finkelman, F.D. et al. Oral but not parental interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med. 1997, 3, 415